(Q39056339)

8 September 2017

Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases (English)

1 reference

8 September 2017

0 references

3

Paul P Tak

1 reference

8 September 2017

John A Hamilton

1

1 reference

PubMed ID

28031576

8 September 2017

Andrew D Cook

series ordinal

2

1 reference

8 September 2017

1 December 2016

1 reference

Nature Reviews Drug Discovery

8 September 2017

1 reference

8 September 2017

16

1 reference

8 September 2017

53-70

1 reference

8 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd.2016.231

8 September 2017

0 references

cites work

Hematopoietic cytokines

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Colony-stimulating factors in inflammation and autoimmunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Stimulation of macrophage plasminogen activator activity by colony-stimulating factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lup

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Colony stimulating factors and myeloid cell biology in health and disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The βc receptor family - Structural insights and their functional implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Targeting GM-CSF in inflammatory diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF increases cross-presentation and CD103 expression by mouse CD8⁺ spleen dendritic cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Systematic cytokine receptor profiling reveals GM-CSF as a novel TLR-independent activator of human plasmacytoid predendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Cutting edge: granulocyte-macrophage colony-stimulating factor is the major CD8+ T cell-derived licensing factor for dendritic cell activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Breaking the vicious cycle between breast cancer cells and tumor-associated macrophages.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Pathogenic IL-23 signaling is required to initiate GM-CSF-driven autoimmune myocarditis in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Conformational Changes in the GM-CSF Receptor Suggest a Molecular Mechanism for Affinity Conversion and Receptor Signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Analysis of the transcriptional networks underpinning the activation of murine macrophages by inflammatory mediators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

A GM-CSF/IL-33 pathway facilitates allergic airway responses to sub-threshold house dust mite exposure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Transgenic expression of GM-CSF in T cells causes disseminated histiocytosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF: a role in immune and inflammatory reactions in the intestine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF: An immune modulatory cytokine that can suppress autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF and uPA are required for Porphyromonas gingivalis-induced alveolar bone loss in a mouse periodontitis model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte macrophage colony-stimulating factor is required for aortic dissection/intramural haematoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF but not IL-17 is critical for the development of severe interstitial lung disease in SKG mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimenta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

CD45 regulates GM-CSF, retinoic acid and T-cell homing in intestinal inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte-macrophage colony-stimulating factor (GM-CSF): a chemoattractive agent for murine leukocytes in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Development and functional specialization of CD103+ dendritic cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Batf3-dependent CD11b(low/-) peripheral dendritic cells are GM-CSF-independent and are not required for Th cell priming after subcutaneous immunization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Differentiation of Inflammatory Dendritic Cells Is Mediated by NF- B1-Dependent GM-CSF Production in CD4 T Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF-responsive monocyte-derived dendritic cells are pivotal in Th17 pathogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Specific Contributions of CSF-1 and GM-CSF to the Dynamics of the Mononuclear Phagocyte System.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Regulation of spontaneous eosinophil apoptosis-a neglected area of importance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Identification of a non-growth factor role for GM-CSF in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through IL-23 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF produced by nonhematopoietic cells is required for early epithelial cell proliferation and repair of injured colonic mucosa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF Promotes Macrophage Alternative Activation after Renal Ischemia/Reperfusion Injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Critical role of the GM-CSF signaling pathway in macrophage pro-repair activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Macrophage activation and polarization: nomenclature and experimental guidelines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF promotes migration of human monocytes across the blood brain barrier.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Colony stimulating factors, cytokines and monocyte-macrophages--some controversies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

T cell expression of granulocyte-macrophage colony-stimulating factor in juvenile arthritis is contingent upon Th17 plasticity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Innate response activator B cells protect against microbial sepsis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte-macrophage colony stimulating factor exerts protective and immunomodulatory effects in cortical trauma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Hematopoietic colony–stimulating factors mediate tumor-nerve interactions and bone cancer pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Distribution of granulocyte-monocyte colony-stimulating factor and its receptor α-subunit in the adult human brain with specific reference to Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF action in the CNS decreases food intake and body weight

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

GM-CSF is not essential for optimal fertility or for weight control.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The role of GM-CSF in adipose tissue inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: Findings from a Phase IIa study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Tissue-Resident Macrophage Ontogeny and Homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Pleiotropic effects of extended blockade of CSF1R signaling in adult mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Control of macrophage lineage populations by CSF-1 receptor and GM-CSF in homeostasis and inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The CSF-1 receptor fashions the intestinal stem cell niche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

M-CSF instructs myeloid lineage fate in single haematopoietic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Hematopoietic cytokines can instruct lineage choice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

CSF1R mutations link POLD and HDLS as a single disease entity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia Caused by a Novel R782G Mutation in CSF1R.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

CSF-1 receptor signaling in myeloid cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Structure and Assembly Mechanism of the Signaling Complex Mediated by Human CSF-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Targeting IL-34 in chronic inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Receptor-type protein-tyrosine phosphatase ζ is a functional receptor for interleukin-34

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Colony-stimulating factor-1 in immunity and inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Colony-stimulating factor-1 receptor inhibitors for the treatment of cancer and inflammatory disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Role of M-CSF-dependent macrophages in colitis is driven by the nature of the inflammatory stimulus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Intra-articular administration of an antibody against CSF-1 receptor reduces pain-related behaviors and inflammation in CFA-induced knee arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

2-(trimethylammonium) ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate suppresses osteoclast maturation and bone resorption by targeting macrophage-colony stimulating factor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Macrophage depletion ameliorates nephritis induced by pathogenic antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Systemic and Cardiac Depletion of M2 Macrophage through CSF-1R Signaling Inhibition Alters Cardiac Function Post Myocardial Infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Emerging Roles for CSF-1 Receptor and its Ligands in the Nervous System

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Regulation of microglial proliferation during chronic neurodegeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Macrophage-Colony Stimulating Factor Derived from Injured Primary Afferent Induces Proliferation of Spinal Microglia and Neuropathic Pain in Rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Cell-Surface and Secreted Isoforms of CSF-1 Exert Opposing Roles in Macrophage-Mediated Neural Damage in Cx32-Deficient Mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Hypoxia enhances the proliferative response of macrophages to CSF-1 and their pro-survival response to TNF.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Among human macrophages polarised to different phenotypes, the M-CSF-oriented cells present the highest pro-inflammatory response to the rheumatoid arthritis-specific immune complexes containing ACPA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Homeostasis in the mononuclear phagocyte system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

CSF-1 signaling mediates recovery from acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Proximal tubule-derived colony stimulating factor-1 mediates polarization of renal macrophages and dendritic cells, and recovery in acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Macrophage colony-stimulating factor (CSF1) controls monocyte production and maturation and the steady-state size of the liver in pigs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Increase in the level of macrophage colony-stimulating factor in patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Urinary levels of RANTES and M-CSF are predictors of lupus nephritis flare

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Colony-stimulating factor-1: a potential biomarker for lupus nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Monoclonal antibodies against macrophage colony-stimulating factor diminish the number of circulating intermediate and nonclassical (CD14(++)CD16(+)/CD14(+)CD16(++)) monocytes in rheumatoid arthritis patient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte colony-stimulating factor and neutrophils--forgotten mediators of inflammatory disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The multifactorial role of neutrophils in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Inhibition of neutrophil apoptosis and modulation of the inflammatory response by granulocyte colony-stimulating factor in healthy and ethanol-treated human volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Technical Advance: Transcription factor, promoter, and enhancer utilization in human myeloid cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Systems approach to phagocyte production and activation: neutrophils and monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

G-CSF: a key regulator of neutrophil production, but that's not all!

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Flare of arthritis with successful treatment of Felty's syndrome with granulocyte colony stimulating factor (GCSF)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Critical role for granulocyte colony-stimulating factor in inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte colony-stimulating factor (G-CSF) plays an important role in immune complex-mediated arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The role of neutrophils and G-CSF in DNFB-induced contact hypersensitivity in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

G-CSF and Neutrophils Are Nonredundant Mediators of Murine Experimental Autoimmune Uveoretinitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

NADPH oxidase controls neutrophilic response to sterile inflammation in mice by regulating the IL-1α/G-CSF axis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Neutrophils: important contributors to tumor progression and metastasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Neutrophil functions in morbidly obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Association of obesity with leukocyte count in obese individuals without metabolic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Regulation of T helper type-1 immunity in hapten-induced colitis by host pretreatment with granulocyte colony-stimulating factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Mice lacking three myeloid colony-stimulating factors (G-CSF, GM-CSF, and M-CSF) still produce macrophages and granulocytes and mount an inflammatory response in a sterile model of peritonitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory Arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Protective role of G-CSF in dextran sulfate sodium-induced acute colitis through generating gut-homing macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The Granulocyte-colony stimulating factor has a dual role in neuronal and vascular plasticity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Hematopoietic colony-stimulating factors: new players in tumor-nerve interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte-Colony Stimulating Factor (G-CSF) induces mechanical hyperalgesia via spinal activation of MAP kinases and PI3K in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte-colony stimulating factor (G-CSF)-induced mechanical hyperalgesia in mice: Role for peripheral TNFα, IL-1β and IL-10

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Exogenous granulocyte colony-stimulating factor exacerbate pain-related behaviors after peripheral nerve injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Early systemic granulocyte-colony stimulating factor treatment attenuates neuropathic pain after peripheral nerve injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Intravenous administration of granulocyte colony-stimulating factor for treating neuropathic pain associated with compression myelopathy: a phase I and IIa clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Seeing old friends from a different angle: novel properties of hematopoietic growth factors in the healthy and diseased brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Crystal structure of the mouse interleukin-3 β-receptor: insights into interleukin-3 binding and receptor activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Cutting edge: basophils are transiently recruited into the draining lymph nodes during helminth infection via IL-3, but infection-induced Th2 immunity can develop without basophil lymph node recruitment or IL-3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

IL-3 Maintains Activation of the p90S6K/RPS6 Pathway and Increases Translation in Human Eosinophils

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The interleukin 3 gene (IL3) contributes to human brain volume variation by regulating proliferation and survival of neural progenitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Signalling by the βc family of cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

CD123, the plasmacytoid dendritic cell phenotypic marker, is abundant in leprosy type 1 reaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Discovery and analysis of inflammatory disease-related genes using cDNA microarrays

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibilit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Role of novel biomarkers of inflammation in patients with stable coronary heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Increased IL-3 serum levels in chronic patients with schizophrenia: Associated with psychopathology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Important role of interleukin-3 in the early phase of collagen-induced arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

IL-3 attenuates collagen-induced arthritis by modulating the development of Foxp3+ regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

IL-3 inhibits TNF-alpha-induced bone resorption and prevents inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

IL-3 contributes to development of lupus nephritis in MRL/lpr mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Innate response activator B cells: origins and functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Interleukin-3 prevents neuronal death induced by amyloid peptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Early start and stop of biologics: has the time come?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Coordinate and noncoordinate colony stimulating factor formation by human monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

Granulocyte colony-stimulating factor induces neutrophils to secrete macrophage colony-stimulating factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.231

"Emergency" granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection

31 March 2020

1 reference

12 December 2020

Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors

1 reference

12 December 2020

Anti-inflammatory effects of granulocyte colony-stimulating factor.

1 reference

12 December 2020

Interleukin-3 and hematopoiesis

1 reference

12 December 2020

Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis

1 reference

12 December 2020

Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies

1 reference

12 December 2020

Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.

1 reference

12 December 2020

The nature and action of granulocyte-macrophage colony stimulating factors

1 reference

12 December 2020

Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor show common biological effects and binding characteristics on human monocytes

1 reference

12 December 2020

Involvement of interleukin-3 in delayed-type hypersensitivity

1 reference

12 December 2020

Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice

1 reference

12 December 2020

The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF

1 reference

12 December 2020

Regulation by interleukin-3 of human monocyte pro-inflammatory mediators. Similarities with granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist

1 reference

12 December 2020

A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus

1 reference

12 December 2020

Circulating levels of interleukin 10 and other cytokines in rheumatoid arthritis treated with cyclosporin A or combination therapy

1 reference

12 December 2020

Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3)

1 reference

12 December 2020

Transcriptional mechanisms underlying sensitization of peripheral sensory neurons by granulocyte-/granulocyte-macrophage colony stimulating factors

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRD.2016.231

1 reference

8 September 2017

1 reference

PubMed ID

28031576